implement process innovation and drive your product from manufacture to market. That’s why the 2019 Cell and Gene Therapy Manufacturing Forum is our biggest yet. With content from over 18 ...
High manufacturing costs limit access to cell and gene therapies and make it harder to bring new products to market, according to VIVEbiotech CEO, Jon Alberdi, who says cheaper production ...
Future Market Insights (FMI) has unveiled a groundbreaking forecast for the global cell and gene therapy manufacturing market, predicting extraordinary growth over the next decade. The latest report ...
Cell & gene therapy manufacturing services encompass a range of specialized processes and technologies aimed at producing cell-based and gene-based therapies. These services are critical in the ...
Researchers have discovered a three-drug combination that enhances the generation of CAR-T cells, a type of cancer immunotherapy, and could improve CAR-T cell production for clinical treatments. The ...
As per Kella Kapnisi, Head of Cell and Gene Therapy at Team Consulting ... for personalized therapies and decentralized manufacturing, real-time process control with the help of advanced inline ...